Entresto (Sacubitril/Valsartan) is the focus of this plain-language guide to its uses, expected effects, and safety considerations. Because it relates to immune and inflammatory conditions, details such as age, other health conditions, pregnancy status, and medicines taken at the same time may affect whether it is suitable. Read the relevant sections alongside the official product leaflet, and ask a qualified clinician or pharmacist about decisions that apply to you.
The FDA approved Entresto to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with chronic heart failure. Current labeling also covers certain children with specific heart failure contexts, an area managed by pediatric heart specialists.
This article explains how the two-in-one design works, why the medicine must never be taken with ACE inhibitors, what side effects to expect, and how treatment is started, adjusted, and monitored over time.
What Is Entresto?
Entresto belongs to a drug class with a long name and a simple idea: the angiotensin receptor-neprilysin inhibitor, or ARNI. Each tablet contains valsartan, a well-established angiotensin receptor blocker (ARB), and sacubitril, a neprilysin inhibitor. The two molecules are joined in a salt complex that separates in the digestive system, so both medicines are absorbed together from one tablet.
Heart failure develops when the heart cannot pump blood well enough to meet the body’s needs, or can only do so at high internal pressures. Over time, the body’s stress hormones tighten blood vessels and promote fluid retention, which briefly helps circulation but ultimately wears the heart down further. Entresto intervenes in two of those stress systems at once, which is why it changed expectations for heart failure therapy when it entered practice.
What Is Entresto Prescribed For?
The core approved use applies to adults with chronic heart failure: Entresto lowers the chance of dying from cardiovascular causes and lowers the chance of being hospitalized because heart failure worsens. Those two outcomes, survival and staying out of the hospital, are the results that matter most in this condition, and they are exactly what the approval is built on.
Current labeling has also been extended to certain pediatric patients aged one year and older in defined heart failure situations. Because pediatric heart failure varies widely by cause, that use belongs in the hands of pediatric cardiology teams, and the details of eligibility are worth confirming against the most recent official label.
Entresto is not an emergency medicine and does not treat sudden fluid overload or acute shortness of breath. It is daily, background therapy intended to slow the disease trajectory, and it works alongside rather than instead of most other heart failure medicines your team prescribes.
How Entresto Works Inside the Body
The valsartan half of the tablet blocks receptors for angiotensin II, a hormone that constricts blood vessels and signals the kidneys to hold onto salt and water. Blocking those receptors helps vessels stay relaxed, lowers the pressure the heart pumps against, and reduces fluid buildup. This action is the same principle behind ARBs that have treated heart failure and high blood pressure for years.
The sacubitril half adds a second, protective push. Neprilysin is an enzyme that breaks down natriuretic peptides, which are the heart’s own helpful messengers: they widen blood vessels, help the body shed excess salt and water through urine, and counter harmful heart remodeling. By inhibiting neprilysin, sacubitril lets those peptides linger and do more work.
Put together, the tablet quiets a harmful hormonal system while amplifying a beneficial one. That dual approach is the practical difference between an ARNI and an ARB or ACE inhibitor alone, and it is the basis for Entresto’s approval outcomes: fewer cardiovascular deaths and fewer heart failure hospitalizations compared with an ACE inhibitor in the pivotal trial behind the drug.
Entresto Tablet Strengths
Because the tablet contains two drugs, its strength is written as two numbers, milligrams of sacubitril first and milligrams of valsartan second. Prescribers typically begin with the lowest strength and step up as blood pressure and lab results allow, aiming for the target dose that produced the best outcomes in studies when a person tolerates it.
| Strength (sacubitril / valsartan) | Commonly described as | Typical role in treatment |
|---|---|---|
| 24 mg / 26 mg | The starting strength | Beginning therapy or restarting after interruptions; used when blood pressure or kidney function requires caution |
| 49 mg / 51 mg | The middle strength | An intermediate step during titration for most adults |
| 97 mg / 103 mg | The target strength | The maintenance dose most adults are titrated toward when tolerated |
Dose decisions belong entirely to your prescriber. Blood pressure, kidney function, and potassium levels determine how quickly the dose climbs, and some people remain on a lower strength permanently because that is what their body tolerates best.
How to Take Entresto
Entresto is taken by mouth, usually twice a day, with or without food. Take it at evenly spaced times, morning and evening, so levels stay steady. Swallow tablets whole; if swallowing is difficult, the official labeling notes the tablets may be crushed and mixed with a small amount of water, and your pharmacist can walk you through that method.
Plan to have your blood pressure and blood chemistry checked regularly, especially during the first weeks and after each dose increase. These checks are how your team confirms the medicine is helping without dropping your pressure too far or disturbing your potassium.
Missed Dose
If you forget a dose, take it when you remember unless it is almost time for the next one. In that case, skip the missed tablet and continue on schedule. Taking two tablets at once can drop blood pressure sharply, so doubling up is never the answer. If you miss doses often, ask your pharmacist about reminder tools or pairing the medicine with a fixed daily habit.
Overdose and Emergency Help
The main danger of an Entresto overdose is severely low blood pressure, which can cause fainting, kidney stress, and falls. Symptoms include extreme dizziness, faintness on standing, and confusion. If an overdose is suspected, contact Poison Control at 1-800-222-1222 or seek emergency care in the United States. Bring the tablet container so responders know the exact product. Treatment focuses on supporting blood pressure and fluids under medical supervision.
Common Side Effects of Entresto
Most side effects relate to the medicine’s blood-pressure effects and its impact on kidney handling of salt and water. Many fade as the body adjusts, particularly during steady titration under a watchful team.
| More common | Less common |
|---|---|
| Low blood pressure, often felt as dizziness when standing | Cough |
| High potassium on blood tests | Worsening kidney function on lab work |
| Lightheadedness or fatigue in the first weeks | Angioedema, which is rare but serious |
| Mild kidney function changes on blood tests | Allergic-type reactions such as rash |
Report dizziness that persists, fainting, or a measurable slowdown in how much you urinate. Your team can often resolve these issues by adjusting the dose, timing, or companion medicines rather than stopping therapy.
Serious Warnings: Fetal Risk, Angioedema, and the ACE-Inhibitor Rule
Entresto carries a boxed warning for fetal toxicity. Drugs that act on the angiotensin system, including valsartan, can injure or kill a developing fetus, and the warning applies throughout pregnancy. Entresto must be stopped as soon as pregnancy is recognized, and alternative therapy chosen with your providers. Anyone who could become pregnant should have a clear contraception plan and discuss it at every visit.
The second serious rule concerns ACE inhibitors. Taking Entresto with an ACE inhibitor, such as lisinopril, enalapril, or ramipril, sharply raises the risk of angioedema, a swelling of the face, lips, tongue, or throat that can block the airway. After the last dose of an ACE inhibitor, at least 36 hours must pass before the first Entresto dose. The same danger applies to a history of angioedema from any cause; people with that history generally need a different medicine. Seek emergency care immediately for any swelling of the face, lips, tongue, or throat, or any trouble breathing or swallowing.
Additional cautions include combining Entresto with aliskiren in people with diabetes, which is not recommended, and the general risk of hyperkalemia, meaning potassium climbing too high. Warning signs of dangerously high potassium are often subtle, such as muscle weakness or an irregular heartbeat, which is why periodic blood tests are part of routine care.
Who Should Use Entresto with Caution?
Heart failure patients usually take several medicines, so interaction management is a central part of safe ARNI therapy.
Medicine Interactions
Beyond the absolute prohibition on ACE inhibitors, avoid layering Entresto with ARBs or aliskiren, since that duplicates the same angiotensin-blocking action. Potassium supplements and potassium-containing salt substitutes can push potassium too high unless your team specifically approves them. NSAID pain relievers, including ibuprofen and naproxen, can strain kidneys already working under reduced blood flow and can blunt the drug’s benefit. Lithium levels can rise and become toxic when combined with ARNI therapy, so anyone using lithium needs close monitoring. Bring a full medicine and supplement list to every appointment.
Pregnancy and Breastfeeding
Because of the boxed warning, Entresto is not used during pregnancy. Tell your cardiologist immediately if you are pregnant or planning pregnancy; the team will arrange a safer alternative and a transition schedule. Breastfeeding raises separate questions, and current labeling advises against nursing during treatment, so discuss feeding options with both your cardiologist and your child’s pediatrician before delivery if possible.
Use in Children and Older Adults
Pediatric use is approved in limited circumstances and requires pediatric cardiology oversight, with weight-based decisions that differ entirely from adult dosing. Older adults often have lower baseline blood pressure, reduced kidney function, and a higher fall risk from dizziness, so prescribers tend to titrate slowly and recheck labs more often. That caution does not exclude older adults; it simply means the schedule may be gentler and monitoring more frequent.
Storage and Handling
Store Entresto at room temperature in its original packaging, protected from moisture and heat. Avoid bathroom storage, where steam and humidity degrade tablets over time. Keep the tablets in the container until the moment you take them, keep the container tightly closed, and store it away from children and pets. If you travel, carry the medicine in your hand luggage in its original packaging. Return unused or expired tablets to a pharmacy take-back program rather than flushing them or discarding them in household trash.
How Quickly Entresto Works and How Long Treatment Lasts
The blood-pressure and circulatory effects of Entresto begin soon after the first doses, but the outcomes the drug is prescribed for, fewer hospitalizations and better survival, build over months of steady use and successful titration. Some people notice improved energy and less breathlessness within weeks as their regimen is optimized; others notice little day to day even while the medicine is quietly protecting the heart.
Entresto is long-term therapy. Heart failure is a chronic condition, and the medicine’s benefits depend on staying on it, reaching the highest tolerated dose, and keeping the rest of the regimen current. Treatment reviews usually happen every few months, with lab work adjusted to how stable your kidney function and potassium are. If side effects interfere, prescribers can often solve them with timing or dose changes rather than abandoning the drug.
Entresto vs Older Heart Failure Medicines
For most of the past few decades, the anchor drugs for chronic heart failure were ACE inhibitors and ARBs. Entresto was built as a direct successor: it keeps the angiotensin-blocking benefit of those older drugs and adds neprilysin inhibition, which the older classes lack. In the head-to-head study that anchored its approval, Entresto outperformed a widely used ACE inhibitor on both cardiovascular death and heart failure hospitalization, which is why guidelines now favor an ARNI for many patients with reduced pumping function.
It also displaced a practical problem. Earlier attempts to pair a neprilysin inhibitor with an ACE inhibitor caused unacceptable angioedema risk, which is precisely why the 36-hour washout rule exists today and why the drug is paired with an ARB rather than an ACE inhibitor.
Generic sacubitril/valsartan products have been approved in the United States, though availability can vary by pharmacy and time. Cost should not silently end a working regimen; ask your pharmacist and care team about options if coverage becomes an issue, since heart failure medicines are usually long term and affordability matters.
Frequently Asked Questions
Why must I wait 36 hours after an ACE inhibitor before starting Entresto?
ACE inhibitors raise levels of bradykinin, a substance that promotes swelling, and Entresto adds its own bradykinin effect through neprilysin inhibition. Combining them without the washout sharply increases the risk of angioedema, which can obstruct the airway. The 36-hour window lets the ACE inhibitor clear before the second drug begins.
Is Entresto a diuretic?
No. It helps the body manage salt and water through hormonal pathways, but it is not a diuretic and does not replace one. Many people with heart failure take both, and fluid pills handle day-to-day fluid swings while Entresto works on the underlying disease process.
Why does my prescriber keep increasing my dose?
Outcomes in the pivotal research improved as doses approached the target strength, so teams titrate upward as long as blood pressure, kidneys, and potassium cooperate. Each step-up is a deliberate trade-off between benefit and tolerability, decided with your lab results in hand.
What should I do if I feel dizzy on Entresto?
Stand up slowly, sit or lie down if the sensation is strong, and avoid driving until it passes. Call your team, especially if dizziness recurs, causes a fall, or comes with fainting. The fix may be as simple as changing a companion medicine or adjusting fluid guidance.
Can I use salt substitutes?
Most salt substitutes replace sodium with potassium chloride, which can push potassium dangerously high on this medicine. Ask your prescriber before using them, and follow any potassium restrictions in your diet plan.
What if I become pregnant while taking Entresto?
Contact your cardiology and obstetric teams immediately and stop the drug only under their direction, since they will switch you to an appropriate alternative. Because of the boxed warning, fetal exposure is treated as urgent throughout pregnancy.
Can Entresto tablets be split or crushed?
The official labeling permits crushing a tablet and mixing it with water for people who cannot swallow tablets whole. Check with your pharmacist before splitting doses on your own, since the tablet design is built around twice-daily whole dosing.
Conclusion
Entresto represents a meaningful step forward in chronic heart failure care by pairing an ARB with a neprilysin inhibitor in one tablet, addressing both a harmful hormonal system and the heart’s own protective messengers. Its benefits accumulate with consistent use, careful titration, and routine monitoring of blood pressure, kidney function, and potassium. The two rules to remember are absolute: never combine it with an ACE inhibitor, and never continue it in pregnancy. With those boundaries respected and a steady partnership with your cardiology team, the medicine offers many people a real chance at fewer hospital stays and a longer, more active life.
Medical Disclaimer
The following section contains the site’s standard legal notice. Heart failure treatment is highly individualized, so use this article as background rather than direction.
Medical Disclaimer: This article is for informational and educational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Follow the official product instructions and seek urgent medical assistance for a medical emergency.
References and Sources
- DailyMed: Entresto (sacubitril/valsartan) prescribing information — official labeling for indications, titration, boxed warning, and washout rules.
- MedlinePlus: Drug Information — consumer drug reference from the National Library of Medicine.
- Drugs@FDA — FDA approval and labeling records for sacubitril/valsartan.
- Entresto official site — manufacturer information on dosing support and patient resources.